Is REPL stock safe? | Glauxie AI

Q: Is REPL stock safe?

Replimune Group, Inc. (REPL) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Sushil Patel. Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that... Employees: 479.

Q: What are the risks of investing in REPL?

Identify key risks of investing in REPL — debt, competition, volatility, and sector headwinds.

Q: Is REPL a good long-term investment?

Evaluate REPL as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does REPL have?

Review REPL total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is REPL stock safe?

🦉

Replimune Group, Inc. (REPL)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOSushil Patel

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is...

Key Executives

Name	Title
Andrew Schwendenman	Chief Accounting Officer & Treasurer
Camilo Garcia	Chief Human Resource Officer
Carolyn Trott	Senior Vice President of Quality Assurance
Christopher Sarchi	Chief Commercial Officer
Emily Luisa Hill	Chief Financial Officer
Konstantinos Xynos	Chief Medical Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

REPL Profile Financials

What are the risks of investing in REPL? Is REPL a good long-term investment? How much debt does REPL have?